The Pi3k Signaling Pathway; From Normal Lymphopoiesis to Lymphoid Malignancies Publisher Pubmed



Kashani B^{1, 2} ; Zandi Z^{1, 2} ; Pourbagherisigaroodi A³ ; Yousefi AM³ ; Ghaffari SH¹ ; Bashash D³ Show Affiliations
Source: Expert Review of Anticancer Therapy Published:2024

Abstract

Introduction: As a vital mechanism of survival, lymphopoiesis requires the collaboration of different signaling molecules to orchestrate each step of cell development and maturation. The PI3K pathway is considerably involved in the maturation of lymphatic cells and therefore, its dysregulation can immensely affect human well-being and cause some of the most prevalent malignancies. As a result, studies that investigate this pathway could pave the way for a better understanding of the lymphopoiesis mechanisms, the undesired changes that lead to cancer progression, and how to design drugs to solve this issue. Areas covered: The present review addresses the aforementioned aspects of the PI3K pathway and helps pave the way for future therapeutic approaches. In order to access the articles, databases such as Medicine Medline/PubMed, Scopus, Google Scholar, and Science Direct were utilized. The search formula was established by identifying main keywords including PI3K/Akt/mTOR pathway, Lymphopoiesis, Lymphoid malignancies, and inhibitors. Expert opinion: The PI3K pathway is crucial for lymphocyte development and differentiation, making it a potential target for therapeutic intervention in lymphoid cancers. Studies are focused on developing PI3K inhibitors to impede the progression of hematologic malignancies, highlighting the pathway’s significance in lymphoma and lymphoid leukemia. © 2024 Informa UK Limited, trading as Taylor & Francis Group.